Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Nicely up on the news, problem is that without follow up contracts, the sp as usual will continue to languish.

Looking at the lack of posts, it looks like interest in this share is lower than the bank rate, which is very understandable due to the lack of firm orders of any note.

Research and trial data, no matter how positive the results are become almost meaningless without some reward from said data, become same as, same as increased sales by the trickle.

Try as I might to be upbeat, even with my token holding, how can anyone be anything but despondent.

I have been a holder for at least 10 years, with promise after promise, with the management talking the same talk with little effect, leaves me wondering how many more years before contracts take the place of trial results or at least equal in prominence.

Whenever I see a RNS, I read it with a sinking heart, expecting before I even start reading that it will be an RNS that is about anything but a contract.

Ewan Phillips said a few months ago, (or was it longer), that they would look at being more proactive toward lack of sales and that they would push more to promote their product, something I suggested years ago, but it was suggested at that time, that being too pushy could have a deterrent effect of future customers.

To date I have not seen any sign of this proposed change in tactics.

I have always followed the ' if it ain't broke, don't fix it', but to my mind the boards strategy ain't working, so it does need fixing.

Deltex have this statement by Sir David Nicholson, Chief executive of the NHS England on it's home page.

Fluid management monitoring technologies can reduce mortality rates for elective procedures, improve the quality of care for more than 800,000 patients a year, and save the NHS at least £400m annually.

Why the hell don't Deltex push this through the media highlighting the lack of action being taken against NHS Trusts in the UK re none or low take up, and yes I do appreciate that it is from other countries that sales will probable come, but if NHS Trusts took up the CardioQ en mass this could only be good for total sales, after all with such a current low take up in the UK how can confidence be shown in the product if the home country won't take it.

Greekman you have highlighted what might be the basic flaws in this ficticious Busniess:
There one discovers a failing Company Management. They are tasked with steering this business and clearly they aren't up to the job.
Either there is a Corporate failure, where they are all equally culpable, or more likely there is a core of unstoppable resistance, perhaps due to seniority or holding a large slice of shares - neither of which should be permitted to control the rigid stance of what should be flexible.

You said there had been promises of changes, at DMAG - but frankly, that's just talk - easy to say but difficult to achieve . . . what is needed, maybe is a change in Management - and PDQ. For else they will find these shares are down to penny status...with the consequence that even their generous share Bonuses... or whatever else fails to drive their efforts....will be worthless promises . . . and any thoughts of raising money for development / new products / etc. will be impossible since no-one will risk buying stock with such a feeble history.

That the business is still selling a single product ( OK, with some variations), demonstrates they have failed to find customer-needs.
I think they should steer clear of NHS - because it is not organised to discovery of new ways to make savings ( and better Outcomes for the Patients ).
All IMHO + I am a LT holder,- - - but sometimes wonder what lies ahead.

Arrgh!

Hi Hangon,

Fully agree.

Nice RNS this morning, although still no large orders.

Continual, plod, plod, plod!

Re RNS Canada,

We finaly have a RNS thats worth something, but How Much, as all it states is 'The first monitor order under the tender has been received.

The tender is initially for three years and covers a number of hospital systems across a single province.

At least they could tell us how many monitors as all this RNS does is leave us guessing!

At last another RNS that is more than a yawn.

In the USA there are a higher proportion of specialist paediatric hospitals in comparison to Europe, with a dedicated hospital for children in most of the larger cities.

Blackrock has finally given up altogether on Deltex by selling their remaining holding of 10,776,297 shares.

RNS.

Another USA hospital account added with an agreement to use a minimum of 65 probes per month.

Not knocking todays news as these are the sort of RNS's we have been waiting for, but to me things are still moving far too slowly.

We need to see many more of these type of contracts making the increase of probes in at least triple figures for the year to make much difference to Deltex's bottom line.

So all probe sales up by good figures and yet the company is haemorrhaging cash (Cash available of £1.3m (31 December 2014, £2.9m).

Even allowing for the following, they had better start moving sales far faster than they are presently achieving............. 'Revenue down £0.3m to £2.7m (2014: £3.0m) Operating loss of £2.1m (2014: operating loss of £1.5m) after planned £1.0m investments in US sales development and operational improvements, exceptional costs of £0.2m.

If sales don't improve quite drastically there will have to be yet another cash raising which will knock investment confidence even further, or they will have to look for a partner (something that as you know I and several other posters have been calling for for years.

I seem to remember that they said (can't remember when) that by year end 2015 that they would be in profit, they are a long way off that!

If todays RNS does not pull Deltex out of the mire, nothing will.

The management have to shout the results of this study as loud as they can, they must not sit back, watch and wait for people to read it, otherwise it will languish along with all those previous studies.

Come on Deltex, there is a great opportunity here, don't waste it!!!!

I now think that Deltex have reached a crossroads, they will either have to

1 Sell out.
2 Enter a partnership.
or
3 Change their tactics from passive selling to more aggressive selling.

Meanwhile as I do not see the sp dropping further due to a possibility of one of the above scenarios I have just bought a few more, something over the last few years I thought I would never do.

Is the tortoise becoming more hare!

Strangely enough as we have not had a RNS this month after a nice few since Sept, I awaited 0700 hrs this morning with anticipation, something I did not dream I would be doing regarding Deltex as several months can easily drift by without any hint of a contract.

But as this mornings RNS states, 'These are the fifth and sixth new platform programme accounts that Deltex has secured since September bringing the total number of US platform accounts to 17, including 11 new ones in the year to date'.

So credit where credits due and it looks like my top up 7 days ago might just pay off.

It is starting to look as if the company will make it good on it's own, better late than never.

Can't remember how many years since I last put a buy rec on this share!

EDIT.......Market been open 45 mins and not one single trade, just shows how the market has stopped watching Deltex, good opportunity going here.

RNS,

So investors are to be offered shares at 4p.

By the time these shares are accepted for trading I would think that there is a very good chance the shares which closed last night at 4.62p will be either on par or could be even lower.

Although I have been more positive of late than I have been for ages, I will not be taking part as I think yet another dilution of company value, is a gamble too far.

If you look at share performance over the last 2 weeks (chart attached), the shares have fallen almost 20% and the market still falling won't help steady the price.

">

Todays RNS re EIS.

No doubt this incentive will encourage some to take up shares in the offer, although I am still not tempted.

It is now 3.9p to buy, not looking good for the offer.

I hope for the companies sake as well as for investors of course, that the sp rises at least to 5p, but looking at the markets and the risk stories doing the rounds, less than 4p could be the price for a while.

Other events aside, Markets are at best "Waiting for something" - and probably not too good - but the situation in this co - Is that good?
I'm wary of Co that don't sell into the UK - it's v.difficult to know what Buyers think . . . but if US Hospitals are buying then there are plenty more that can use Deltex probes . . . . that's good.... Although rather too slow in happening!

The sp is just below the Offer price( = 4p - DYOR ), but they have this Loan Note to replay - why diidn't they raise that money by a Offer ( like this one)..? Paying that Fund 8% p.a. over 3-years looks careless, but presumably they thought it wouldn't affect the sp...?

Dunno - I may still buy a few - ( it's an Av. Dn. ), and What of the Future?
-does anyone think this will see 20p - even in the next 3-years?

Then, for that dosh, I can W,W&S and enjoy those memories . . .

Hi Hangon,

We may well see 20p again, but to my mind there have seen too many false dawns to be drawn in again to buy more shares.

Result of the fund raising.

Deltex has received valid acceptances from Qualifying Shareholders in respect of 10,693,408 Open Offer Shares, including applications for 6,303,861 Open Offer Shares under the Excess Application Facility. This represents approximately 57.0 per cent. of the maximum Open Offer Shares available under the Open Offer.

The low take up says it all regarding the lack of confidence in the companies future.

The last similar fund raiser for another IAM company I am invested in was around 4 times over subscribed and yet the sp is now lower in that company than it was a month ago, the date of the offer, which does not bode well for a company that's offer was under subscribed.

It matters little what individuals think, positive or negative, it's the collective of 43.0 per cent that the market will concentrate on.

I expect the sp to drop by .25 to .50p by close today.

greekman, I fear you may be right, but the sp has risen since the "uncertainty" they'd get anything . . . . so I guess the money raised "should" be spent carefully.... However, they've not used it to make profits in the past, so while I subscribed a little, I'm only "hopeful"
They are supplying decent "Kit" - but it's into the US so difficult o understand exactly how they are meeting expectations . . . from this end it's not good and they really need to develop extra kit . . . and not just the same in pink/chrome etc.
Execs need to spend some time in the US to discover what Kit is missing - and satisfy that need - pref. something reasonably simple with a small customer-base ( This avoids being overloaded with demand, allowing Competition in. ).... pref. it would be something that's unrelated to existing kit, but which is "At home" in a hospital
environment; so their limited Sales-Force can sell "twice-per-trip".

I wonder - did the Issue cover the Debt they wanted to clear?
+ I suspect the Issue wasn't a "good-enough deal" to excite larger Shareholders.... so the Advisors badly misjudged the Market - it's particularly tough at this time.

Yr comments re other Co. placings . . .
Were they in the Hype regions, I wonder?
Folks can pay silly money for stocks without L-T track records
- whereas Deltex has one that's clearly getting worse! Er, IMHO. and I suspect that was why it only got half the amount.
EDIT-(5April2016)- Low take-up is also a factor of the prevailing mind-set . . . with folks thinking China may implode and US in Debt too, it's possible that for Deltex folks are unduly worried....but all-in-all I fear Deltex needs mind-changing at the TOP. . . and this 2016-money will go the same way as previous Dilution.
Sadly I have little regard for this business and the sp rather agrees with that.
The fact is they can't sell this in the UK - so why don't they make something that does sell - thereby their profits "could" be spent on Investors+Reserach . . . although I get the impression there is minimal Research . . . as they believe the path to Riches only needs finding the right clothing . . . whereas I think a decent Map and GPS would be more useful.
EDIT-(11May2016).Release of new WA probe in the UK ( Yet available in US, since Nov"15)....ah well they needed somewhere to place the older product. . . . sp 3.38p
EDIT-(22May2016)-sp up 16%, but still below 5p.
EDIT (03Oct2016) Greekman - re. partnering/probes....Sphere looks promising...?
EDIT (3Nov2016)-sp+10% (~3.5p) on Southern NHS buying £30K-worth . . . Huh!
EDIT (17Nov2016)-Greekman, it's small pots...but does indicate they can break into fresh ground - if NHS continues to by "probes" then / more / elsewhere in UK.
EDIT(7Nov2016)-7% fall today, are the rats leaving already? What I fail to understand is why whoever designed probes+m/c hasn't thought of ANOther product, which would add to Sales and Medic-Interest. Yr point about "partnering" I would change to "Agent" - where they take a 'related' product ( so the same salesforce needs only minor training ), from a Company that isn't active (or too Small) in D's territories. This is beneficial to both parties, esp. [DEMG]. if they can rebrand -OR- if the Probes m/c can be used to power/display Both products. When I was working for Co's- they were open to Customer needs, that's the way to best conduct "research" - no point in developing Kit that no-one wants/Afford.... The probe/NHS link is slightly good.....but look at the "Time" it's taken. Are the Sales-force part-timers? Too many Execs aren't out selling! IMHO.
EDIT (7March2017)-sp 3.6p doesn't look like Mkt believes there's much Prospect... Oh dear!
EDIT ( 26May2017)- sp 4p1 It rose on news they're offering "Veterinary" probes ( Dogs/Cats ), which is another Market-stream . . . . also "owners" may wish to have the best-chance of success, etc. Pity they can't do Horses - that's where real money lies, but maybe they just shoot them? Dunno. It's much better than "no-News"
EDIT (11July2017)- sp 3.6 looks like it's not recovering... & News re Korea?
EDIT(21Sept2017)- Seems they've sold two "xxx" to France. sp 3.16 though Dirs seem to be buying - but not £100k-worth.

Hi Hangon,

Fully agree re other kit, which means I have to comment on my old chestnut re Deltex partnering, but as you know I have mentioned it so many times.

As for the other companies placings, not really in the hype area as they have the backing of some very big players.

I do though agree that over subscribe does not always mean that the future is rosy, thinking about tech companies for example.